(20S)-ginsenoside Rg3 increases expression ISO Map2 (Mus musculus) 6480464 ginsenoside Rg3 results in increased expression of MAP2 mRNA CTD PMID:24599032 (S)-3,5-dihydroxyphenylglycine increases phosphorylation EXP 6480464 3 and 5-dihydroxyphenylglycine results in increased phosphorylation of MAP2 protein CTD PMID:15893642 (S)-3,5-dihydroxyphenylglycine multiple interactions EXP 6480464 [3 more ... CTD PMID:15893642 (S)-colchicine decreases expression ISO MAP2 (Homo sapiens) 6480464 Colchicine results in decreased expression of MAP2 mRNA CTD PMID:34748853 1,1-dichloroethene decreases expression ISO Map2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of MAP2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Map2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MAP2 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO Map2 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO Map2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of MAP2 mRNA CTD PMID:14976129 17beta-estradiol multiple interactions ISO MAP2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP2 mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO MAP2 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of MAP2 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Map2 (Mus musculus) 6480464 2 more ... CTD PMID:34627992 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Tretinoin results in increased expression of MAP2 mRNA] CTD PMID:34627992 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,5-hexanedione decreases expression EXP 6480464 2 and 5-hexanedione results in decreased expression of MAP2 protein modified form CTD PMID:20554699 2-hydroxypropanoic acid decreases expression ISO MAP2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MAP2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO MAP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of MAP2 mRNA CTD PMID:21179406 2-palmitoylglycerol increases expression ISO MAP2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of MAP2 mRNA CTD PMID:37199045 3',5'-cyclic AMP multiple interactions ISO MAP2 (Homo sapiens) 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of MAP2 protein CTD PMID:33713149 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of MAP2 mRNA CTD PMID:27914987 3,4-methylenedioxymethamphetamine increases expression ISO Map2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO MAP2 (Homo sapiens) 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of MAP2 mRNA CTD PMID:29698629 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] CTD PMID:26676567 5-fluorouracil increases expression ISO MAP2 (Homo sapiens) 6480464 Fluorouracil results in increased expression of MAP2 mRNA CTD PMID:16510598 9-cis-retinoic acid increases expression ISO MAP2 (Homo sapiens) 6480464 Alitretinoin results in increased expression of MAP2 protein CTD PMID:23500671 9-cis-retinoic acid decreases expression ISO MAP2 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of MAP2 mRNA and Alitretinoin results in decreased expression of MAP2 protein CTD PMID:36805303 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MAP2 protein CTD PMID:29524570 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAP2 protein CTD PMID:30096436 acrylamide multiple interactions EXP 6480464 calpeptin inhibits the reaction [Acrylamide results in decreased expression of MAP2 protein] and calpeptin inhibits the reaction [Acrylamide results in increased expression of MAP2 protein] CTD PMID:29524570 and PMID:30096436 aflatoxin B1 decreases methylation ISO MAP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of MAP2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO MAP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MAP2 mRNA CTD PMID:34748853 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MAP2 mRNA CTD PMID:33354967 agomelatine multiple interactions EXP 6480464 agomelatine results in increased expression of and results in increased phosphorylation of MAP2 protein CTD PMID:22160164 aldicarb multiple interactions ISO MAP2 (Homo sapiens) 6480464 Aldicarb promotes the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 all-trans-retinoic acid multiple interactions ISO MAP2 (Homo sapiens) 6480464 [NTF3 protein co-treated with Tretinoin] results in increased expression of MAP2 protein more ... CTD PMID:16996685 more ... all-trans-retinoic acid affects expression ISO MAP2 (Homo sapiens) 6480464 Tretinoin affects the expression of MAP2 protein CTD PMID:35594436 all-trans-retinoic acid multiple interactions ISO Map2 (Mus musculus) 6480464 2 more ... CTD PMID:34627992 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of MAP2 mRNA CTD PMID:24977338 all-trans-retinoic acid decreases expression ISO MAP2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP2 mRNA and Tretinoin results in decreased expression of MAP2 protein CTD PMID:21934132 and PMID:36805303 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MAP2 protein CTD PMID:16944780 and PMID:17130476 all-trans-retinoic acid increases expression ISO Map2 (Mus musculus) 6480464 Tretinoin results in increased expression of MAP2 mRNA and Tretinoin results in increased expression of MAP2 protein CTD PMID:16424397 and PMID:34627992 all-trans-retinoic acid increases expression ISO MAP2 (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP2 mRNA and Tretinoin results in increased expression of MAP2 protein CTD PMID:15464216 more ... aluminium sulfate (anhydrous) multiple interactions EXP 6480464 aluminum sulfate inhibits the reaction [Excitatory Amino Acid Agents results in increased metabolism of MAP2 protein] CTD PMID:10428068 amantadine decreases expression ISO MAP2 (Homo sapiens) 6480464 Amantadine results in decreased expression of MAP2 mRNA CTD PMID:34748853 ammonia multiple interactions EXP 6480464 Ammonia inhibits the reaction [1-amino-1 more ... CTD PMID:15893642 ammonia increases phosphorylation EXP 6480464 Ammonia results in increased phosphorylation of MAP2 protein CTD PMID:15893642 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP2 mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of MAP2 protein CTD PMID:16483693 antimycin A decreases expression ISO MAP2 (Homo sapiens) 6480464 Antimycin A results in decreased expression of MAP2 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO MAP2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MAP2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO MAP2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAP2 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Map2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MAP2 protein CTD PMID:22013134 arsane affects methylation ISO MAP2 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP2 gene CTD PMID:25304211 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAP2 protein CTD PMID:35993674 arsane decreases expression ISO Map2 (Mus musculus) 6480464 Arsenic results in decreased expression of MAP2 mRNA CTD PMID:24019935 arsenic atom affects methylation ISO MAP2 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP2 gene CTD PMID:25304211 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAP2 protein CTD PMID:35993674 arsenic atom decreases expression ISO Map2 (Mus musculus) 6480464 Arsenic results in decreased expression of MAP2 mRNA CTD PMID:24019935 arsenous acid decreases expression ISO MAP2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MAP2 protein CTD PMID:15894607 azithromycin decreases expression ISO Map2 (Mus musculus) 6480464 Azithromycin results in decreased expression of MAP2 mRNA CTD PMID:37995777 azoxystrobin decreases expression ISO MAP2 (Homo sapiens) 6480464 azoxystrobin results in decreased expression of MAP2 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO Map2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of MAP2 mRNA CTD PMID:20713471 benzo[a]pyrene affects methylation ISO MAP2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MAP2 5' UTR and Benzo(a)pyrene affects the methylation of MAP2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Map2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAP2 mRNA CTD PMID:22610609 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAP2 protein CTD PMID:21467743 Benzo[k]fluoranthene decreases expression ISO Map2 (Mus musculus) 6480464 benzo(k)fluoranthene results in decreased expression of MAP2 mRNA CTD PMID:26377693 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of MAP2 mRNA CTD PMID:16648578 bisphenol A decreases expression ISO Map2 (Mus musculus) 6480464 bisphenol A results in decreased expression of MAP2 mRNA and bisphenol A results in decreased expression of MAP2 protein CTD PMID:32156529 and PMID:32512148 bisphenol A increases methylation ISO MAP2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of MAP2 gene CTD PMID:31601247 bisphenol A decreases expression ISO MAP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of MAP2 mRNA and bisphenol A results in decreased expression of MAP2 protein CTD PMID:20678512 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP2 mRNA CTD PMID:25181051 bucladesine multiple interactions ISO MAP2 (Homo sapiens) 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of MAP2 mRNA CTD PMID:29698629 butanal decreases expression ISO MAP2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of MAP2 mRNA CTD PMID:26079696 cadmium atom increases expression ISO MAP2 (Homo sapiens) 6480464 Cadmium results in increased expression of MAP2 mRNA CTD PMID:21172416 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of MAP2 mRNA CTD PMID:17293106 Calpeptin multiple interactions EXP 6480464 calpeptin inhibits the reaction [Acrylamide results in decreased expression of MAP2 protein] and calpeptin inhibits the reaction [Acrylamide results in increased expression of MAP2 protein] CTD PMID:29524570 and PMID:30096436 capsaicin increases expression ISO MAP2 (Homo sapiens) 6480464 Capsaicin results in increased expression of MAP2 mRNA CTD PMID:18405923 carbaryl multiple interactions ISO MAP2 (Homo sapiens) 6480464 Carbaryl promotes the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 CGP 52608 multiple interactions ISO MAP2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP2 gene] CTD PMID:28238834 chlordecone increases expression ISO Map2 (Mus musculus) 6480464 Chlordecone results in increased expression of MAP2 mRNA CTD PMID:33711761 chlorohydrocarbon decreases expression EXP 6480464 Hydrocarbons and Chlorinated results in decreased expression of MAP2 mRNA CTD PMID:22872703 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] CTD PMID:26676567 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of MAP2 mRNA CTD PMID:15079866 chlorpyrifos decreases expression ISO Map2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of MAP2 mRNA CTD PMID:20350560 chlorpyrifos increases expression ISO Map2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of MAP2 protein CTD PMID:26018426 choline multiple interactions ISO Map2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP2 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP2 mRNA CTD PMID:22023808 cisplatin decreases expression ISO MAP2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of MAP2 mRNA CTD PMID:27392435 clobetasol decreases expression ISO Map2 (Mus musculus) 6480464 Clobetasol results in decreased expression of MAP2 mRNA CTD PMID:27462272 cobalt dichloride increases expression ISO Map2 (Mus musculus) 6480464 cobaltous chloride results in increased expression of MAP2 protein CTD PMID:16772336 cocaine affects expression EXP 6480464 Cocaine affects the expression of MAP2 mRNA CTD PMID:20187946 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of MAP2 mRNA CTD PMID:16076954 colforsin daropate hydrochloride increases expression ISO MAP2 (Homo sapiens) 6480464 Colforsin results in increased expression of MAP2 protein CTD PMID:34897981 copper atom multiple interactions ISO MAP2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAP2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO MAP2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAP2 mRNA CTD PMID:20971185 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of MAP2 mRNA CTD PMID:26577399 cyanocob(III)alamin multiple interactions EXP 6480464 Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:38049026 Cyclopamine multiple interactions EXP 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of MAP2 protein] CTD PMID:24464877 cyclosporin A increases expression ISO MAP2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of MAP2 mRNA CTD PMID:20106945 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of MAP2 mRNA CTD PMID:22528246 cyproconazole increases expression ISO Map2 (Mus musculus) 6480464 cyproconazole results in increased expression of MAP2 mRNA CTD PMID:22045034 cytarabine decreases expression ISO MAP2 (Homo sapiens) 6480464 Cytarabine results in decreased expression of MAP2 protein CTD PMID:21198554 cytarabine increases expression ISO MAP2 (Homo sapiens) 6480464 Cytarabine results in increased expression of MAP2 mRNA CTD PMID:21198554 DAPT multiple interactions ISO Map2 (Mus musculus) 6480464 N-(N-(3 and 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA] CTD PMID:24929042 DDT decreases expression EXP 6480464 DDT results in decreased expression of MAP2 mRNA CTD PMID:30207508 deguelin decreases expression ISO MAP2 (Homo sapiens) 6480464 deguelin results in decreased expression of MAP2 mRNA CTD PMID:33512557 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MAP2 protein CTD PMID:11311531 diarsenic trioxide decreases expression ISO MAP2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MAP2 protein CTD PMID:15894607 dibutyl phthalate increases expression ISO Map2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of MAP2 mRNA CTD PMID:21266533 dichlorvos multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Dichlorvos results in increased phosphorylation of MAP2 protein] CTD PMID:16635102 dichlorvos increases phosphorylation EXP 6480464 Dichlorvos results in increased phosphorylation of MAP2 protein CTD PMID:11282359 and PMID:16635102 dieldrin multiple interactions ISO MAP2 (Homo sapiens) 6480464 Dieldrin promotes the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 dihydrolipoic acid multiple interactions ISO Map2 (Mus musculus) 6480464 dihydrolipoic acid inhibits the reaction [NGF protein results in increased expression of MAP2 protein] CTD PMID:21462292 diquat increases expression ISO MAP2 (Homo sapiens) 6480464 Diquat results in increased expression of MAP2 mRNA CTD PMID:21172416 diuron increases expression EXP 6480464 Diuron results in increased expression of MAP2 mRNA CTD PMID:25152437 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MAP2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO MAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO MAP2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MAP2 mRNA CTD PMID:29803840 doxorubicin increases expression ISO MAP2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of MAP2 mRNA CTD PMID:30031762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP2 mRNA CTD PMID:29391264 enzalutamide decreases expression ISO MAP2 (Homo sapiens) 6480464 enzalutamide results in decreased expression of MAP2 mRNA CTD PMID:29581250 enzalutamide multiple interactions ISO MAP2 (Homo sapiens) 6480464 KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mRNA] CTD PMID:29581250 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of MAP2 protein CTD PMID:20829428 ethanol decreases expression ISO Map2 (Mus musculus) 6480464 Ethanol results in decreased expression of MAP2 protein CTD PMID:23500890 ethanol multiple interactions ISO Map2 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of MAP2 mRNA and TLR4 gene mutant form inhibits the reaction [Ethanol results in decreased expression of MAP2 protein] CTD PMID:23500890 and PMID:30319688 folic acid multiple interactions ISO Map2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP2 mRNA CTD PMID:20938992 folic acid decreases expression ISO Map2 (Mus musculus) 6480464 Folic Acid results in decreased expression of MAP2 mRNA CTD PMID:25629700 FR900359 affects phosphorylation ISO MAP2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MAP2 protein CTD PMID:37730182 gamma-hexachlorocyclohexane multiple interactions ISO MAP2 (Homo sapiens) 6480464 Hexachlorocyclohexane promotes the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP2 mRNA CTD PMID:33387578 ginsenoside Rb1 increases expression ISO Map2 (Mus musculus) 6480464 ginsenoside Rb1 results in increased expression of MAP2 mRNA CTD PMID:24599032 ginsenoside Rd increases expression ISO Map2 (Mus musculus) 6480464 ginsenoside Rd results in increased expression of MAP2 mRNA and ginsenoside Rd results in increased expression of MAP2 protein CTD PMID:24599032 ginsenoside Re increases expression ISO Map2 (Mus musculus) 6480464 ginsenoside Re results in increased expression of MAP2 mRNA and ginsenoside Re results in increased expression of MAP2 protein CTD PMID:24599032 ginsenoside Rg1 increases expression ISO Map2 (Mus musculus) 6480464 ginsenoside Rg1 results in increased expression of MAP2 mRNA CTD PMID:24599032 glutathione multiple interactions ISO MAP2 (Homo sapiens) 6480464 Glutathione inhibits the reaction [Particulate Matter results in decreased expression of MAP2 mRNA] CTD PMID:28153600 glyphosate increases expression ISO MAP2 (Homo sapiens) 6480464 Glyphosate results in increased expression of MAP2 mRNA and Glyphosate results in increased expression of MAP2 protein CTD PMID:35485992 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of MAP2 mRNA CTD PMID:15079866 heptachlor multiple interactions ISO MAP2 (Homo sapiens) 6480464 Heptachlor promotes the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 hexachlorophene multiple interactions ISO MAP2 (Homo sapiens) 6480464 Hexachlorophene inhibits the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 hydrogen peroxide affects expression ISO MAP2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of MAP2 protein CTD PMID:21179406 isoniazide affects expression ISO Map2 (Mus musculus) 6480464 Isoniazid affects the expression of MAP2 mRNA CTD PMID:22131109 ivermectin decreases expression ISO MAP2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of MAP2 protein CTD PMID:32959892 kainic acid multiple interactions ISO Map2 (Mus musculus) 6480464 PTGS2 affects the reaction [Kainic Acid results in increased expression of MAP2 mRNA] CTD PMID:21589914 kainic acid increases expression ISO Map2 (Mus musculus) 6480464 Kainic Acid results in increased expression of MAP2 mRNA CTD PMID:21589914 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of MAP2 protein CTD PMID:15372504 L-ascorbic acid multiple interactions ISO MAP2 (Homo sapiens) 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of MAP2 protein CTD PMID:33713149 L-methionine multiple interactions ISO Map2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP2 mRNA CTD PMID:20938992 lead diacetate decreases expression ISO Map2 (Mus musculus) 6480464 lead acetate results in decreased expression of MAP2 mRNA CTD PMID:22013134 leflunomide decreases expression ISO MAP2 (Homo sapiens) 6480464 leflunomide results in decreased expression of MAP2 mRNA CTD PMID:28988120 LY294002 decreases expression ISO Map2 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MAP2 protein CTD PMID:29129800 maneb multiple interactions ISO Map2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of MAP2 mRNA more ... CTD PMID:23963992 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of MAP2 mRNA CTD PMID:28801915 melatonin multiple interactions ISO Map2 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of MAP2 mRNA] CTD PMID:23963992 melittin decreases expression ISO Map2 (Mus musculus) 6480464 Melitten results in decreased expression of MAP2 protein CTD PMID:37678661 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of MAP2 mRNA and Methamphetamine results in decreased expression of MAP2 protein CTD PMID:17407499 methotrexate increases expression ISO MAP2 (Homo sapiens) 6480464 Methotrexate results in increased expression of MAP2 mRNA CTD PMID:24449571 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of MAP2 gene CTD PMID:35440735 methylglyoxal decreases expression ISO MAP2 (Homo sapiens) 6480464 Pyruvaldehyde results in decreased expression of MAP2 protein CTD PMID:37431083 methylmercury chloride decreases expression ISO Map2 (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of MAP2 mRNA CTD PMID:21385734 and PMID:22555245 methylmercury chloride increases expression ISO MAP2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of MAP2 mRNA CTD PMID:23179753 methylmercury chloride decreases expression ISO MAP2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of MAP2 mRNA CTD PMID:22555245 miconazole decreases expression ISO Map2 (Mus musculus) 6480464 Miconazole results in decreased expression of MAP2 mRNA CTD PMID:27462272 morphine decreases expression EXP 6480464 Morphine results in decreased expression of MAP2 mRNA CTD PMID:15183518 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in decreased expression of MAP2 protein CTD PMID:11681848 N,N-diethyl-m-toluamide decreases expression EXP 6480464 DEET results in decreased expression of MAP2 protein CTD PMID:11681848 N-acetyl-L-cysteine multiple interactions ISO Map2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:28499986 N-acetyl-L-cysteine multiple interactions ISO MAP2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MAP2 mRNA] CTD PMID:28153600 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of MAP2 mRNA CTD PMID:19638242 nickel dichloride multiple interactions ISO MAP2 (Homo sapiens) 6480464 nickel chloride promotes the reaction [Tretinoin results in increased expression of MAP2 mRNA] CTD PMID:25614230 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of MAP2 mRNA CTD PMID:20303128 nimodipine multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Dichlorvos results in increased phosphorylation of MAP2 protein] CTD PMID:16635102 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of MAP2 mRNA CTD PMID:33484710 Nivalenol increases expression ISO Map2 (Mus musculus) 6480464 nivalenol results in increased expression of MAP2 mRNA CTD PMID:35016910 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of MAP2 mRNA CTD PMID:15079866 oxaliplatin increases expression ISO MAP2 (Homo sapiens) 6480464 oxaliplatin results in increased expression of MAP2 mRNA CTD PMID:16510598 ozone multiple interactions ISO Map2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MAP2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAP2 mRNA CTD PMID:34911549 panobinostat increases expression ISO MAP2 (Homo sapiens) 6480464 panobinostat results in increased expression of MAP2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO MAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP2 mRNA CTD PMID:27188386 paracetamol increases expression ISO MAP2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MAP2 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP2 mRNA CTD PMID:33387578 paraquat multiple interactions ISO Map2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of MAP2 mRNA more ... CTD PMID:23963992 PD123319 multiple interactions EXP 6480464 PD 123319 inhibits the reaction [AGT protein results in increased expression of MAP2 protein] CTD PMID:17068200 permethrin multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in decreased expression of MAP2 protein CTD PMID:11681848 permethrin decreases expression EXP 6480464 Permethrin results in decreased expression of MAP2 protein CTD PMID:11681848 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of MAP2 mRNA CTD PMID:17616710 phenylmercury acetate increases expression ISO MAP2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of MAP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MAP2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP2 mRNA CTD PMID:27188386 physostigmine multiple interactions ISO Map2 (Mus musculus) 6480464 Physostigmine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:28499986 picoxystrobin decreases expression ISO MAP2 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of MAP2 mRNA CTD PMID:33512557 poly(vinylpyrrolidone) multiple interactions ISO Map2 (Mus musculus) 6480464 [Silver Compounds co-treated with Povidone] results in decreased expression of MAP2 protein CTD PMID:35697184 potassium chromate decreases expression ISO MAP2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MAP2 mRNA CTD PMID:22714537 potassium dichromate decreases expression ISO Map2 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of MAP2 mRNA CTD PMID:23608068 progesterone increases expression ISO MAP2 (Homo sapiens) 6480464 Progesterone results in increased expression of MAP2 mRNA CTD PMID:18037150 progesterone decreases expression ISO MAP2 (Homo sapiens) 6480464 Progesterone results in decreased expression of MAP2 mRNA CTD PMID:21795739 progesterone increases expression EXP 6480464 Progesterone results in increased expression of MAP2 protein CTD PMID:16054770 pyrimidifen decreases expression ISO MAP2 (Homo sapiens) 6480464 pyrimidifen results in decreased expression of MAP2 mRNA CTD PMID:33512557 pyrroloquinoline quinone decreases expression ISO MAP2 (Homo sapiens) 6480464 PQQ Cofactor results in decreased expression of MAP2 mRNA CTD PMID:28578007 rac-lactic acid decreases expression ISO MAP2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MAP2 mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MAP2 protein CTD PMID:24464877 resveratrol multiple interactions EXP 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of MAP2 protein] CTD PMID:24464877 risperidone increases expression EXP 6480464 Risperidone results in increased expression of MAP2 mRNA CTD PMID:15079866 rotenone multiple interactions ISO MAP2 (Homo sapiens) 6480464 Rotenone inhibits the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 rotenone decreases expression ISO Map2 (Mus musculus) 6480464 Rotenone results in decreased expression of MAP2 protein CTD PMID:35919817 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAP2 mRNA CTD PMID:32481507 rotenone decreases expression ISO MAP2 (Homo sapiens) 6480464 Rotenone results in decreased expression of MAP2 mRNA CTD PMID:33512557 Salidroside increases expression ISO Map2 (Mus musculus) 6480464 rhodioloside results in increased expression of MAP2 mRNA and rhodioloside results in increased expression of MAP2 protein CTD PMID:24929042 Salidroside multiple interactions ISO Map2 (Mus musculus) 6480464 N-(N-(3 more ... CTD PMID:24929042 sarin decreases expression EXP 6480464 Sarin results in decreased expression of MAP2 protein CTD PMID:27639427 SB 431542 multiple interactions ISO MAP2 (Homo sapiens) 6480464 [4-(5-benzo(1 more ... CTD PMID:27188386 more ... scopolamine decreases expression ISO MAP2 (Homo sapiens) 6480464 Scopolamine results in decreased expression of MAP2 protein CTD PMID:22096544 scopolamine multiple interactions ISO MAP2 (Homo sapiens) 6480464 Ashwagandha inhibits the reaction [Scopolamine results in decreased expression of MAP2 protein] and withanone inhibits the reaction [Scopolamine results in decreased expression of MAP2 protein] CTD PMID:22096544 sevoflurane multiple interactions ISO Map2 (Mus musculus) 6480464 APOE protein alternative form inhibits the reaction [Sevoflurane results in increased expression of MAP2 protein] CTD PMID:35575159 sevoflurane increases expression ISO Map2 (Mus musculus) 6480464 Sevoflurane results in increased expression of MAP2 protein CTD PMID:35575159 silver atom decreases expression ISO MAP2 (Homo sapiens) 6480464 Silver results in decreased expression of MAP2 protein CTD PMID:27593553 silver(0) decreases expression ISO MAP2 (Homo sapiens) 6480464 Silver results in decreased expression of MAP2 protein CTD PMID:27593553 silver(1+) nitrate decreases expression ISO Map2 (Mus musculus) 6480464 Silver Nitrate results in decreased expression of MAP2 protein CTD PMID:35697184 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of MAP2 protein CTD PMID:26676567 sirolimus multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] and Chloroquine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] CTD PMID:26676567 sodium arsenate decreases expression ISO Map2 (Mus musculus) 6480464 sodium arsenate results in decreased expression of MAP2 mRNA CTD PMID:22131109 sodium arsenite increases expression ISO MAP2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP2 mRNA CTD PMID:22714537 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAP2 protein CTD PMID:35993674 sodium arsenite decreases expression ISO MAP2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MAP2 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO Map2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of MAP2 mRNA CTD PMID:22131109 streptozocin multiple interactions ISO Map2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] and Physostigmine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:28499986 streptozocin multiple interactions EXP 6480464 Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:38049026 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of MAP2 protein CTD PMID:38049026 streptozocin decreases expression ISO Map2 (Mus musculus) 6480464 Streptozocin results in decreased expression of MAP2 protein CTD PMID:28499986 sulforaphane increases expression ISO MAP2 (Homo sapiens) 6480464 sulforaphane results in increased expression of MAP2 mRNA CTD PMID:31838189 tetrachloromethane affects expression ISO Map2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of MAP2 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAP2 mRNA CTD PMID:33387578 thifluzamide decreases expression ISO MAP2 (Homo sapiens) 6480464 thifluzamide results in decreased expression of MAP2 mRNA CTD PMID:33512557 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MAP2 mRNA CTD PMID:33387578 trichloroethene increases phosphorylation ISO MAP2 (Homo sapiens) 6480464 Trichloroethylene results in increased phosphorylation of MAP2 protein CTD PMID:26018768 trichostatin A increases expression ISO MAP2 (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP2 mRNA CTD PMID:24935251 trichostatin A affects expression ISO MAP2 (Homo sapiens) 6480464 trichostatin A affects the expression of MAP2 mRNA CTD PMID:28542535 triclosan decreases expression ISO MAP2 (Homo sapiens) 6480464 Triclosan results in decreased expression of MAP2 mRNA CTD PMID:30510588 triphenyl phosphate decreases expression ISO Map2 (Mus musculus) 6480464 triphenyl phosphate results in decreased expression of MAP2 mRNA CTD PMID:35752650 triptonide decreases expression ISO Map2 (Mus musculus) 6480464 triptonide results in decreased expression of MAP2 mRNA CTD PMID:33045310 Tryptanthrine increases expression ISO MAP2 (Homo sapiens) 6480464 tryptanthrine results in increased expression of MAP2 protein CTD PMID:23500671 valproic acid increases expression ISO Map2 (Mus musculus) 6480464 Valproic Acid results in increased expression of MAP2 mRNA CTD PMID:22045034 valproic acid decreases expression ISO MAP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MAP2 mRNA CTD PMID:34742744 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of MAP2 mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MAP2 mRNA CTD PMID:29427782 valproic acid decreases expression ISO Map2 (Mus musculus) 6480464 Valproic Acid results in decreased expression of MAP2 mRNA CTD PMID:22131109 valproic acid multiple interactions ISO MAP2 (Homo sapiens) 6480464 Valproic Acid promotes the reaction [[4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 valproic acid affects expression ISO Map2 (Mus musculus) 6480464 Valproic Acid affects the expression of MAP2 mRNA CTD PMID:26072468 valproic acid increases expression ISO MAP2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP2 and Valproic Acid results in increased expression of MAP2 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO MAP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP2 mRNA CTD PMID:25979313 and PMID:26072468 valsartan multiple interactions EXP 6480464 Valsartan promotes the reaction [AGT protein results in increased expression of MAP2 protein] CTD PMID:17068200 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of MAP2 mRNA CTD PMID:25423262 WIN 55212-2 decreases expression ISO Map2 (Mus musculus) 6480464 (3R)-((2 more ... CTD PMID:12237329 zoledronic acid decreases expression ISO MAP2 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of MAP2 mRNA CTD PMID:24714768